Cargando…

Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy

SIMPLE SUMMARY: Immunotherapy is emerging as an improved systemic treatment for select patients with advanced unresectable hepatocellular carcinoma. An objective response is reported in 30% of patients, yet a complete response allowing for curative-intent surgery is rare. Locoregional therapies seem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raj, Roma, Wehrle, Chase J., Aykun, Nihal, Stitzel, Henry, Ma, Wen Wee, Krishnamurthi, Smitha, Estfan, Bassam, Kamath, Suneel, Kwon, David C. H., Aucejo, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650763/ https://www.ncbi.nlm.nih.gov/pubmed/37958394 http://dx.doi.org/10.3390/cancers15215220

Ejemplares similares

Characterization of Salivary and Plasma Metabolites as Biomarkers for HCC: A Pilot Study
por: Hershberger, Courtney E., et al.
Publicado: (2023)

Comparison of characteristics and outcomes of young‐onset versus average onset pancreatico‐biliary adenocarcinoma
por: Jayakrishnan, Thejus, et al.
Publicado: (2023)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021)

Serum albumin predicts survival in patients with hilar cholangiocarcinoma
por: Waghray, Abhijeet, et al.
Publicado: (2017)

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma
por: Fountzilas, Christos, et al.
Publicado: (2020)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
por: Györi, Georg P., et al.
Publicado: (2017)

Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
por: Biondetti, Pierpaolo, et al.
Publicado: (2021)

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
por: Iezzi, Roberto, et al.
Publicado: (2023)

Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?
por: Wu, Xiao, et al.
Publicado: (2023)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
por: Luo, Laihui, et al.
Publicado: (2022)

Racial disparities negatively impact outcomes in early‐onset colorectal cancer independent of socioeconomic status
por: Kamath, Suneel D., et al.
Publicado: (2021)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study
por: Moon, Andrew M., et al.
Publicado: (2023)

Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
por: Leng, Kai-Ming, et al.
Publicado: (2017)

TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy
por: Song, Kangjian, et al.
Publicado: (2021)

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC
por: Chen, Bo, et al.
Publicado: (2021)

Case Report: Solitary metastasis to the appendix after curative treatment of HCC
por: Zhang, Zun-Yi, et al.
Publicado: (2023)

Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
por: Ahn, Soomin, et al.
Publicado: (2013)

Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
por: Ariizumi, Shun-ichi, et al.
Publicado: (2014)

(18)F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches
por: Kornberg, Arno, et al.
Publicado: (2019)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy
por: Feng, Hanxin, et al.
Publicado: (2022)

Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy
por: Guo, Zhe, et al.
Publicado: (2015)

The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy
por: TOKUMITSU, YUKIO, et al.
Publicado: (2014)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
por: Zhang, Li-xiang, et al.
Publicado: (2021)

Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
por: Yoon, Jae Hyun, et al.
Publicado: (2021)

Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019)

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
por: Saddawi-Konefka, Robert, et al.
Publicado: (2021)

Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis
por: Zhang, Zhiming, et al.
Publicado: (2021)

Prediction of early recurrence of HCC after hepatectomy by contrast-enhanced ultrasound-based deep learning radiomics
por: Zhang, Hui, et al.
Publicado: (2022)

Case report and literature review: Isolated HCC- recurrence in gallbladder after curative resection
por: Zhang, Shi-Ran, et al.
Publicado: (2023)

Recurrence after Curative Resection for Intrahepatic Cholangiocarcinoma: How to Predict the Chance of Repeat Hepatectomy?
por: Langella, Serena, et al.
Publicado: (2021)

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
por: Liang, Bin-Yong, et al.
Publicado: (2022)

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation
por: Chen, I-Hsuan, et al.
Publicado: (2023)

Surgical and Oncological Outcomes of Salvage Hepatectomy for Locally Recurrent Hepatocellular Carcinoma after Locoregional Therapy: A Single-Institution Experience
por: Minagawa, Takuya, et al.
Publicado: (2023)

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery
por: Qin, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kiktidcqqchuml3hrmn8j645mo